In a series of papers (Tang, Chin and Rao, 2008; and Tang, Petrie and Rao 2006 & 2007), we have tried to improve on a mortality-based health status indicator, namely age-at-death, and its associated health inequality indicators that measure the distribution of age-at-death. The main contribution of these papers is to propose a frontier method to separate avoidable and unavoidable mortality risks. This has facilitated the development of a new indicator of health status, namely the Realization of Potential Life Years (RePLY). The RePLY measure is based on the concept of a "frontier country" that, by construction, has the lowest mortality risks for each age/sex group amongst all countries. The mortality rates of the frontier country are used as a proxy for the unavoidable mortality rates, and the residual between the observed mortality rates and the unavoidable mortality rates are considered as avoidable morality rates. In this approach, however, countries at different levels of development are benchmarked against the same frontier country without considering their heterogeneity. The main objective of the current paper is to control for national resources in estimating (conditional) unavoidable and avoidable mortality risks for individual countries. This allows us to construct a new indicator of health status -Realization of Conditional Potential Life Years (RCPLY). Furthermore, in the previous papers, we construct the frontier using a data envelopment method without controlling for noise in the data. The second objective of the paper is to use Stochastic Frontier Analysis (SFA) methods to improve on the frontier estimation. The paper presents empirical results from a dataset of life tables for 167 countries from the year 2000, compiled and updated by the World Health Organization. Measures of national average health status and health inequality based on RePLY and RCPLY are presented and compared.
Introduction
Measuring health inequality within a population is more difficult than measuring its average health status. A key reason is the lack of reliable indicators of individual health status. In the case that such indicators do exist, like body mass index and self-reported health status 1 , data are typically available only for individual countries at sporadic years. This makes comparisons of health inequalities across countries or over time very difficult. A health status measure that seems to be relatively free from this data problem is age-at-death, i.e. length-oflife. In fact, age-at-death was one of the first indicators to be used to measure health inequality (Le Grand 1987 , 1989 .
Using age-at-death as an indicator of health status has several merits. Firstly, there is little ambiguity in deciding whether a person is alive or dead. Secondly, other things equal, better health should lead to a higher age-at-death. Thirdly, vital statistics are one of the mostly commonly collected data, even in many poor countries. As a result, age-at-death data are available for many countries as well as over time. The publication of life tables, which standardize mortality statistics, further facilitates cross country and temporal comparisons of health status.
However, age-at-death also has its limitations as a health status indicator. Firstly, it is uninformative about the morbidity of individuals while alive. A person who died at an old age but had suffered from long term illness may arguably be worse off than a person who lived a shorter but otherwise very healthy life. Secondly, and more importantly, age-at-death does not distinguish between avoidable and unavoidable deaths. The very fact that everyone must die at some point of his or her life is the strongest evidence that some mortality risks are unavoidable. To the extent that unavoidable deaths, by definition, cannot be prevented by intervention, they should have relatively smaller immediate policy and resources implications than avoidable deaths. A new indicator that focuses only on the age-at-death of avoidable death (i.e. age-at-avoidable-death) has been recently introduced by Tang, Chin and Rao (TCR) (2008) to address the second issue. Building on that effort, Tang, Petrie and Rao (TPR) (2006; 2007) further integrate the proportions of avoidable and unavoidable deaths and ageat-avoidable-death into a more comprehensive health status indicator called the Realization of
Potential Life Years (RePLY).
The RePLY indicator measures the extent to which people have realized their potential life years. For people whose deaths are unavoidable, by definition, their RePLY measure will be equal to one; for people whose deaths are avoidable, their RePLY measure will be equal to their age-at-death as a proportion of their potential age-at-death. The numbers of avoidable and unavoidable deaths are estimated based on the probabilities at which the two types of deaths occur in each age/sex group. For health inequality analysis, RePLY can be used to replace age-at-death to measure health status on an individual basis and, hence, its distribution across the population. The fact that RePLY has filtered out the natural mortality differences between ages and sexes means that it can provide more useful information about whether an intervention for a given age/sex group is likely to be effective in reducing its morality in the short to medium run and, thus, about the cost effectiveness of health resource allocation.
The estimation of potential age-at-death in TPR (2006; 2007) is based on the identification of a "frontier profile" of mortality rates of 191 countries. This leads to the concept of a reference or frontier country 2 , whose mortality rates, by assumption, are a proxy for unavoidable morality risks. The gap between the mortality rate of each age/sex group of a country and that of the frontier country is an indication of the country's excess or avoidable mortality risks for that group. It is postulated that if the country has the same amount of resources as the frontier country and uses it as efficiently, it could close the mortality gap. The use of a large cross-country dataset allows us to compare and contrast the levels of health status and inequality across both developing and developed countries. The drawback of this approach is that the frontier profile of mortality rates are, as expected, determined by the mortality rates of mostly high income countries. This means that the health performance of low income countries is benchmarked against that of their affluent counterparts. However, it is unrealistic to expect that the government of poorer countries could provide the same level of health care services to their people as in rich countries. To the extent that income is likely to be a crucial determinant of mortality rates, the avoidable mortality gap currently identified in the RePLY framework does not indicate how much improvement these poor countries, themselves, could possibly achieve in the short run through better usage or allocation of the resources at their disposal. In a sense, the RePLY framework measures health inequality from a global perspective and what the global community could achieve by a reallocation of resources within as well as across countries. In summary, if our interest is on global health inequality, RePLY based measures will be useful; on the other hand, if our interest is on health inequality within countries, then we should benchmark the health performance of an individual country against a reference country that has comparable resources at its disposal.
The main focus of this paper is on the second case, that is, to develop a health status indicator that takes into account of the short term resource constraints faced by countries, and use it to measure health inequality within countries. TPR (2006; 2007) estimate the frontier mortality profile using a data envelopment method. As a non-parametric method, the method does not account for the natural variation of death rates (i.e. noise) for a particular year. The stochastic variation in mortality rates could affect the position of the frontier and thus the accuracy of resulting health status and inequality measures. The second objective of this paper is thereby to control for this natural variation (i.e. noise) in the data in order to obtain a more robust estimation of the mortality profile of the frontier country. To summarize, this paper aims to improve on the estimation of the frontier mortality profile by taking into account the short-term resource constraint for an 6 individual country and minimise the effect of the data noise on the indicator. To achieve these objectives, we modify the RePLY measure in the following two, progressive, steps. This is because, as explained in section 3, RCPLY has embodied a measure of technical efficiency of the health systems; as a result, comparison of RCPLY across countries is essentially a comparison of the efficiency of their health systems.
The rest of the paper is organized as follows. Section 2 explains the concepts of unavoidable mortality risk and RePLY. Section 3 explains the concept of RCPLY and how it can be constructed using DEA methods. Section 4 extends the methodology discussion to using SFA methods to estimate RCPLY. We relegate some technical details of the actual estimation procedures to Appendix 1. Section 5 explains the data used in the empirical work.
Section 6 reports and discusses the empirical findings. The last section offers some concluding remarks. A shortcoming of this approach is that a single region is unlikely to have the lowest mortality rate for all age groups. Woolsey, Uemura and TCR circumvent this problem by constructing the reference unavoidable morality rates using data from multiple regions or countries.
Unavoidable Mortality Risks and Realization of Potential
Amongst all these studies, TCR are the only ones that use international mortality data that cover countries of all levels of income and development -191 countries in total. Using a data envelopment method, TCR construct a hypothetical frontier country that has the lowest mortality rates for each of the age/sex groups. The mortality rates of a frontier country are then used as the unavoidable mortality rates.
The data envelopment method used by TCR is as follows. Suppose there are K countries and the probability of a person in country k who survives to age x will die before reaching the next birthday is denoted by x k q . 6 Let x q be the probability of dying for a person of the same age in the hypothetical frontier country. Then, x q is defined as
The first two columns on the left hand side of Table 1 shows the country that has the lowest mortality risks for each age/sex group using the dataset in this paper and therefore contribute to the construction of the frontier mortality profile. This list is not the same as that in TCR because firstly, the World Health Organization has subsequently updated their dataset to provide more accurate estimates; and secondly, we only consider 167 countries due to the lack of other data (details of the dataset are discussed in section 5). The use of a slightly smaller dataset has negligible effects on the identification of the frontier mortality profile, as reflected in the fact that the list of countries on It should be noticed that q is a conditional probability as it is conditional on the person having survived from birth till age x. However, we simply use the term "probability" rather than "conditional probability" throughout the paper so that we can preserve the word "conditional" for cases where the probabilities are measured after controlling for income. 7 This section is drawn from Tang, Petrie & Rao (2006). death that occurs at age x, the person in concern has not fully realized his potential length-of- 
Since unavoidable mortality risks are assumed to be invariant across countries, the number of unavoidable deaths, x s k U , of the group x s k can be estimated by
where x s k N is the size of the group in the stationary population 9 .
The number of avoidable deaths for the group, x s k A , is equal to the number of all deaths minus unavoidable deaths:
(1 / ) 
Conditional Unavoidable Mortality Risks and Realization of Conditional Potential
Life Years (RCPLY)
GDP per capita as a measure of national resources
The assumption of unavoidable mortality risks being country invariant is based on the assertion that unavoidable mortality risks are driven by, besides genes, globally available technology. A limitation of this assertion in practice is that even though technology is globally available, its purchase and adoption is resource dependent. For instance, poor countries are typically in great need of even basic medical supplies and personnel. Since the reference mortality rates constructed by TCR is constructed using a simple envelopment of all the countries without controlling for development levels, they are dominated by countries with high income levels. Even though income is not fixed in the long term, it is of great inertia in the short to medium term. As a result, the estimates of avoidable mortality rates for low income countries, based on the global frontier of unavoidable mortality rates, are only a very long-run concept with little relevance to policy in the short to medium term, unless resources can be redistributed from other countries.
In this paper we propose to measure avoidable mortality risks after controlling for country-specific resources as measured by GDP per capita in the estimation of the frontier mortality profile. Obviously, income is not the only dimension of health-related resources.
Other important resources (broadly defined) include education, health expenditure, and natural environment. GDP per capita is the only resource measure used in this paper for a number of reasons. First of all, since we are dealing with national level data, GDP per capita is arguably the most useful single measure of a country's available resources. Secondly, what we want to control for is the total amount of resources available to a nation, not the allocation of resources amongst competing usages. This is because even if nations are constrained by the total amount of resources available to them, they still can manoeuvre the allocation of resources across different health-related sectors, such as health, education, water and sanitation, and housing.
Another possible determinant of health is education. In this regard, it is important to distinguish between education expenditure and education level. The education level of the population, as measured by, for instance, average years of schooling, is a stock measure, while education expenditure is a flow measure. The education level of the population is related to education expenditure in the past and therefore cannot be changed in the short to medium term. Therefore, it could be argued that in principle education level should be included as another resource measure besides GDP per capita. However, in practice education is known to be highly correlated with income. Furthermore, although there are existing data sets on average years of schooling, especially the widely used Barro and Lee (2000) dataset, the limitation of its country coverage means that the inclusion of education would substantially reduce our sample size. Lastly, in the stochastic frontier analysis, we find that the estimates are sensitive to model specifications, and become less stable as more input variables are used (see later sections for more details on this aspect). Therefore, in the current paper we decide not to include education level or education expenditure.
Lastly, countries in different parts of the world are exposed to very different kind of climate and biological environment in general. To the extent that many environmental factors cannot be manipulated in the short run or even in the long run in individual countries, one may argue that those factors should be controlled for in estimating the frontier mortality
profile. An issue of controlling for environmental factors is that it is not clear that they have a monotonic relationship with mortality rates. This is problematic in DEA estimation as it requires a prior knowledge on the direction of the contribution of an input factor to output.
The SFA method does not require such a prior knowledge but still requires a specified functional form, and again confronts the aforementioned model sensitivity issue. Therefore, we leave the environmental issue for further research.
All in all, based on theoretical and practical considerations, in this paper we use only GDP per capita to indicate the amount of resources available to each country. When the mortality risks of a country is benchmarked against the mortality risks of the best performing countries regardless of their income levels, we will obtain the original RePLY; and when benchmarked against those of similar income levels, we will obtain a new measure -
Realization of Condition Potential Life Years (RCPLY).
In developing the concepts of (unconditional) avoidable and unavoidable mortality risks, three assumptions have been made as stated in section 2. These assumptions are expanded to include conditional avoidable and conditional unavoidable mortality risks. The fourth assumption is a straightforward extension of A1: conditional avoidable and conditional unavoidable mortality risks are mutually exclusive (A4). However, since conditional unavoidable mortality risks are contingent on a country's income, it must be country specific, like conditional avoidable mortality risks. Therefore, the extensions of A2 and A3 can be condensed into a single one: conditional avoidable and conditional unavoidable mortality risks are age, sex and country specific 11 , and time variant (as technology changes) (A5).
The general frontier approach to the determination of conditional and unconditional mortality risks

The frontier function
In this section we describe the frontier approach to determine conditional and unconditional mortality risks for different age/sex groups. Consider a person of age x and sex s. Let the survival probability of the person reaching the next age bracket be x s p , which is equal to one minus the probability of death (i.e. 1
The survival probability is used as the output of the "health production" in order to ensure a monotonically increasing functional relationship with the input measure -GDP per capita (expressed in logarithmic terms). The frontier approach stipulates that, for a given technology level, the survival probability is a function of income, y:
where the function is assumed to be different for each age/sex groups. The function x s f shows the maximum feasible survival probability for a given level of income, where all the observed survival probabilities, x s p , are below or equal to the maximum feasible level of x s p .
In addition, we allow x s f to exhibit variable returns to scale in the DEA estimation. This is because, although we already use log income as the input, the underlying relationship between p and y could be more or less convex than what a logarithmic function allows. In fact, in the vast majority of cases, the estimates indicate that it exhibits decreasing returns to scale.
Conditional unavoidable mortality risks
We demonstrate the concepts using Figure 1 . This figure is specific to a particular age/sex group. Suppose country k has a real per capita income of k y and let the observed survival probability for country k be x s k p . The solid line shows the value of the frontier function x s f at different income levels. Given the frontier function, it is possible to identify the maximum feasible survival probability conditional on the income level k y :
By definition, we haveˆˆ1 1 "global frontier country" is the hypothetically best performing country of all income levels; that is, they locate on different income regions of the same frontier rather than on different frontiers. For countries with different income levels, they will have different local frontier countries to benchmark against, but they will still have the same global frontier country.
When benchmarked against the local frontier country, the number of conditional unavoidable deaths,
The number of conditional avoidable deaths for the group,
A , is equal to the number of all deaths minus that of conditional unavoidable deaths:
Unconditional unavoidable mortality risks
In Figure 1 , the maximum achievable survival probability for a given income level k y is given by ˆx s k p . However, the maximum achievable survival probability from the frontier function as income increases is given by 
. That is, the number of conditional unavoidable deaths will be at least as large as the unconditional unavoidable deaths. This is because, when the inequality holds, some of the unconditional unavoidable deaths are due to the fact that country k has fewer resources than some other countries. The number of deaths that could be avoided if the country is given sufficient resources is given by
Measures of technical efficiency
Using Figure 1, we can define the level of technical efficiency 13 achieved by a country. The technical efficiency (TE) measure shows the survival probability attained by a country relative to the maximum achievable survival probability at its income level. Thus the TE measure for country k with income k y is given by
By definition, we have 0 1
The technical efficiency measure can be used as an indicator of efficiency of the health system in a given country. Countries that lie on the frontier are considered as technically fully efficient. An important point in the determination of technical efficiency is that country k is benchmarked against and compared with the best performing countries with similar income levels. Thus, improving the TE levels could be considered as an achievable target as set by peer countries with similar levels of income.
It should be noticed that RCPLY thus already embodies this measure of technical efficiency. This is because the closer x s k p to ˆx s k p is, the closer RCPLY to one will be. This implies that the efficiency of national health systems will affect the average health status of the population (as reflected in group or national average measures of RCPLY) and its health inequality (as reflected in RCPLY based inequality indicators). The reason why efficiency matters for a nation's average health status is obvious: the more efficient the health system is, the more lives could be saved with the same resources. The reason why efficiency also matters for a nation's health inequality, however, needs some explanation. Recall that our notion of health equality is that everyone realizes his or her potential life years to the same degree. For those who died of unavoidable causes, they had all the resources required to live up to their conditional potential or even more; for those who died of avoidable causes, they could have been saved and, thus, realized more of their potential if they were given more resources or if their resources were used more efficiently. So here the health system can affect health inequality through either better allocation of resources amongst those who are in need (i.e. improving allocation efficiency) or better usage of the allocated resources (i.e. improving technical efficiency). For instance, a reallocation of resources from those who died of unavoidable causes to those died of avoidable causes could increase the overall equality, especially if the former has used more resources that what they just needed to live up to their potential. On the other hand, even if there is no reallocation of resources, a more efficient usage of the allocated resources can also affect health inequality. This is because, the more efficient the health system is, the smaller the proportion of conditional avoidable deaths. Since conditional unavoidable deaths and avoidable deaths are of different RCPLY scores, this will lead to change in RCPLY based health inequality measures. However, it should be emphasized that there is no a prior guarantee that higher efficiency will lead to greater health equality. For instance, if there is large improvement in usage efficiency but limited improvement in allocation efficiency, it is possible that the health improvement in some segments of the population will be much larger than that in other segments, resulting in a rise in average health status but deterioration in health equality.
Frontier Estimation
The most important step in constructing RCPLY is to identify the frontier. In order to identify the frontier it is necessary to have a cross-country data set for each age/sex group. There are two methods available for this purpose, the data envelopment analysis (DEA) and the stochastic frontier analysis (SFA).
Estimating the frontier using Data Envelopment Analysis (DEA)
The DEA method constructs a frontier using a piecewise linear frontier similar to the one drawn in Figure 1 . Since we have survival probabilities expressed as a function of only one determinant, income, it is possible to construct these frontiers using simple graphical methods. 14 This is illustrated in Figure 2 using the survival probabilities of males aged 75 of 167 countries. This age/sex group is selected because the large variation in its survival probabilities across countries that makes the visual identification of the frontier much easier.
The DEA method has identified five countries with full efficiency, Tanzania, Mongolia, Nicaragua, Mexico, and Japan. These countries, by definition, have zero conditional avoidable mortality risks for this particular age/sex group, and all other countries' mortality rates are benchmarked against combinations of their mortality rates. Amongst these five countries, Japan has the highest survival probability; therefore, it is the only country that has zero unconditional avoidable mortality risks for this age/sex group.
Tanzania is a special case and worth mentioning here. It sits on the "edge" of the frontier mainly because it has the lowest income level ($498) amongst all the countries in the dataset. 15 Due to its status of having the lowest income, even if its survival probability drops to very low, it will remain technically fully efficient. 16 In fact, this is the case for all DEA estimations in this paper, making it the only country that has zero conditional avoidable deaths for all age/sex groups and, thus, perfect conditional health equality! Since this is an artifact of the country being the observation of the lowest income in the dataset, we will not 14 It is necessary to use linear programming methods to identify the frontier and there by calculating technical efficiencies when multiple inputs and/or multile outputs are present. Details of the general DEA methodology can be found in Coelli, Rao, O'Donnell and Battese (2005) . 15 We have also tried to include an artificial observation of zero input and zero output in the dataset. But it does not change the results for Tanzania or others. 16 It will cease to become a peer country only if we include an artificial observation of zero input and zero output in the dataset while Tanzania's survival probability drops to sufficiently low.
pay much attention to its result in most of the discussion. But we keep it in the estimation, otherwise, the same situation will hold for the country with the second lowest income level.
Applying the same procedure to all other age/sex groups, we can obtain lists of countries (reported in Table 1 ) that have zero conditional avoidable mortality risks for all the groups. The lists of countries are noticeably lengthy, especially for ages below 30. A long list typically reflects a more continuous convex frontier for the low income countries, indicating that controlling for income is important in considering the efficiency of the health system. The first possible explanation for this result is that income may be more important in determining the mortality rates for the younger age groups than for the older one. The second explanation, but related to the first one, is that as the size of the population typically gets smaller at high ages, the natural variation (noise) in mortality rates becomes relatively more important as compared to income in driving the observed mortality rates of the high age groups.
Amongst the low income countries, besides the special case of Tanzania, Armenia, Mongolia, Tajikistan, Vietnam, and Yemen are the "regular features" of table, indicating the high relative effectiveness of their health systems given the available resources. The effectiveness of these countries' health systems may be due to the fact that they allocate proportionally more of their national resources to health and/or they use their health-related resources more effectively. In order to identify the relative importance of these two factors, we need to control for the amount of national resources being spent on health. We leave this issue to further research.
Estimating the frontier using Stochastic Frontier Analysis
As a non-parametric method, DEA has a limitation of not controlling for noise in the data. This is exacerbated by the fact that only 40 out of the 191 countries in the dataset used by TCR have reasonably complete vital statistics, and the mortality data for the rest of the countries are based on estimations from available data. Although TCR has conducted a number of sensitivity tests to ensure the frontier profile of unavoidable mortality risks is robust to outliers, the accuracy of the frontier estimation could be further strengthened by using Stochastic Frontier Analysis (SFA) methods.
When we control for GDP per capita, a linear probability stochastic frontier model for
where
is an age/sex specific constant term, Here k v is supposed to capture the random measurement errors and/or stochastic variations of the survival probability, and k u captures the inefficiency of the health system.
Due to the existence of the stochastic term k v , the predicted conditional unavoidable mortality rate, i.e. the mortality rate of the local frontier country, is defined as 
A potential problem of (13) is that, the predicted value of the local frontier country's mortality rate, ˆx s k q , may lie outside [0, 1] . This problem is more likely to arise when the income level gets closer to the higher end of the income spectrum and the observed survival probability also gets closer to its upper bound. Non-linear models can be utilised to prevent such a scenario. In this paper, we adopt a logit model specification:
The mortality rate of the local frontier country is now given by 17 The cap above β is to indicate that it is an estimated value. It should not be confused with the cap above p or q, which is to indicate conditional survival probability or conditional mortality risks. A < if we use (9). Since this "out-performance" is assumed to be due to stochastic errors, we can resolve this problem by setting
Data
The proposed method is applied to year 2000 life tables of 191 countries, compiled and recently updated by the World Health Organization in 2002. However, the limitation of GDP per capita data restricts our analysis to 167 countries only. Almost all 24 countries being excluded are small countries, including a number of countries that have very low mortality rates like Monaco, San Marino, Andorra, and Brunei. These countries were prominent in the identification of the global frontier of mortality profile in the studies by TCR and TPR. The removal of these countries will therefore remove some of the concerns that the small size of these countries leads to bias in the estimation of the frontier mortality rates.
Life tables provide information on the estimated probability of death in each age/sex group and subsequently the number of deaths for a stationary population. The stationary population of a country is constructed by repeatedly subjecting the population to the same age/sex specific mortality rate profiles as observed in the year of survey until the demographic structure becomes static. At the same time, the number of births is standardized. Since the number of deaths for each age/sex group in the stationary population remains unchanged over time, they provide the expected number of deaths in each age group associated with a population cohort. As a result, the calculation in this study is based on the stationary population rather than the actual population.
18
Data on real GDP per capita (PPP, international dollars) is drawn from the World Development Indicators database. We use the average of 1990 to 1999 data to smooth short term fluctuations as well as to mitigate possible reverse causality from health to income.
Empirical Results
Results from Data Envelopment Analysis
Recall that in total we have proposed three health status measures: RePLY-DEA, RCPLY-DEA, and RCPLY-SFA. Based on each of these measures, we can construct various group and national average health status and health inequality indicators. In order to keep the discussion focused, we only report the results of one national average health status indicator and one health inequality indicator: respectively the mean and the Gini coefficient of the corresponding health status measures across all age/sex groups.
The summary statistics of the indicators are reported in Table 2 and the full results can be founded in Appendix 2. Except for income, the statistics are calculated based on the results of 166 out of the 167 countries used in the estimation; the results for Tanzania are not included due to the issue related to its lowest income status as discussed before.
It can be seen from Table 2 that there are huge differences in income across the 167 countries, with the richest (Luxembourg) being almost eight times that of the poorest 18 The actual population is useful to scale up the absolute size of the stationary population if one is interested in measuring the average health status or health inequality for a multi-country region or the world as a whole.
(Tanzania status will be at least as high as the unconditional ones. This is because an unconditional avoidable death is constructed when countries are benchmarked against the global frontier of unavoidable mortality risks, while a conditional avoidable death is constructed when a country is benchmarked against the local frontier country's mortality risks, which must be equal to or higher than the global frontier country's mortality risks by definition. Therefore, for any country, the number of conditional unavoidable deaths must be equal to or larger than that of unconditional unavoidable deaths, implying that a non-negative number of people will see their health status measures change from less than unity to unity under the RCPLY-DEA indicator compared to under the RePLY-DEA indicator. Furthermore, those who did not receive a health status of unity will still see their health status measure increase under the new conditional indicator. Therefore, no group will register a lower health status when the indicator is shifted from RePLY-DEA to RCPLY-DEA, but some groups will register a higher health status as a consequence, raising the overall health status of the nation. 19 It is based on the mean figure in column (2)/(1). 20 It is based on the ratio of the standard deviations of (2) and (1), not the standard deviation of (2)/(1). 21 Again, it is based on the mean figure in column (5)/(4).
As expected, in general average RePLY-DEA is positively related to income level.
Therefore, countries at the high end of the average RePLY-DEA spectrum are mostly OECD countries and those at the low end are mostly Sub-Sahara African countries. For countries with average RePLY-DEA close to one, the differences between the two measures are relatively small. However, the difference between the two measures, in general widens as average RePLY-DEA falls. In percentage terms, the change for Malawi is the biggest, 22 with its average RCPLY-DEA 74% higher than its average RePLY-DEA, followed by Sierra Leone which is 62% higher. The difference essentially reflects the gap between the mortality risks of the local and the global frontier countries. In general, the RePLY-DEA Gini coefficient is negatively related to income. Since the rich countries' mortality risks profiles are very close to that of the global frontier country, most of their deaths are classified unavoidable deaths and have a health status measure equal to unity for RePLY-DEA. As a result, health inequality in these countries is very small despite there being inequalities in age-at-death. For the poor countries, a larger proportion of deaths are classified as avoidable deaths, and avoidable deaths of different age/sex groups are of different health statuses as measured by RePLY-DEA. As a result, health inequality in the poor countries tends to be bigger relative to their more affluent counterparts.
When RCPLY-DEA is used instead to measure health status, it not only increases the number of conditional unavoidable deaths, but also decreases the potential life expectancy of those who died from conditional avoidable deaths, resulting in a larger RCPLY-DEA measure for these individuals. These lead to a reduction of the overall inequality as measured by the Gini coefficient. As shown in Figure 3 that the impact on the measured health status is larger for the low income countries when resources are controlled for, therefore, correspondingly the impact on the measured health inequality is also larger for this group of countries.
Comparison across Data Envelopment and Stochastic Frontier Analyses
In this section, we compare the results of RCPLY-SFA and RCPLY-DEA. Table 2 shows that, on average, a country's own average RCPLY-SFA is about 5 percent higher than that its in SFA in general will lower the global and local frontier mortality risks for all age/sex groups and that will raise the RCPLY-SFA measure above the RCPLY-DEA measure for most countries. As most age/sex groups of a country will get closer to the unity health outcome, it lowers the RCPLY-SFA Gini coefficient compared to RCPLY-DEA Gini coefficient (even though it is not necessary at a prior). The exception of Tanzania and Malawi is likely due to the fact that these countries have very low incomes and therefore forces the DEA frontier around it to have a very different shape from the SFA frontier (which takes a particular functional form).
The results in Table 2 also show that the differences of using DEA and SFA to measure average health status and health inequality, while discernable, are not as substantial as the differences between using RePLY and RCPLY. This implies that, controlling for resources constraint, at least quantitatively, is more important than controlling for stochastic variation in the current dataset.
To further illustrate the effects of controlling for income and noise in the data, we list the top and bottom 10 performers in terms of average health status and health inequality in Table 3 . The first outstanding feature of the table is that countries that perform well in terms of average health also do so in terms of health equality under each of the three health status indicators, and similarly for those performing poorly. This is illustrated even more clearly in
Figures 7 to 9, which plot respectively the Gini coefficients of the three indicators against their own national average. It can be seen that the two measures are highly correlated, with most of the dispersion present in the poorest performing countries. This strong result suggests that, once the natural mortality differences between all age/sex groups are removed from the health status indicator, there is a strong correlation between national average health status and within-country health inequality. However, it should be noticed that because of the data constraint of life tables, we can only measure the health inequalities between different age/sex groups plus the inequalities between the avoidable and the unavoidable deaths within each group, but not that amongst the unavoidable deaths within each group. This means that, further refinement of health inequality measures should focus on within age/sex group inequalities.
The second feature of Table 3 is that the ranking of the countries have changed substantially across the three measures of health status. Since average health and health inequalities are highly correlated, the average and inequality measures give the same picture.
Based on RePLY-DEA, all the top 10 performers are high income, OECD countries. However, when switching to RCPLY-DEA, two low income countries, Yemen and Vietnam, and an upper-middle income country, Costa Rica, make it into the top 10 list. In particular, Yemen and Vietnam achieve an average RCPLY-DEA close to 1 (also see Figure 3 ). When further moving to RCPLY-SFA, three more middle income countries, Jamaica, Syrian, and Chile also make it to the top 10. These, indicate that these countries are very effective amongst all other countries in their income groups in terms of producing the best mortality outcomes.
On the contrary, changes in the bottom 10 countries are much smaller across different indicators. In particular, across different indicators, the list bottom 10 remains dominated by more or less the same group of Sub-Sahara African countries.
Concluding Remarks
The current paper represents another stage in our efforts to improve on health status and associated health inequality indicators. These efforts started with an attempt to improve on the "classic" indicator, age-at-death, which resulted in the development of age-at-avoidable-death (TCR). The methodology of TCR was subsequently used in developing a new indicator, RePLY. The current paper proposes an improved measure, namely RCPLY. At each stage of this evolutionary process, additional factors are controlled for. From age-at-death to age-atavoidable-death, we have controlled for the differences between avoidable and unavoidable deaths by omitting unavoidable deaths all together; from age-at-avoidable-death to RePLY, we have controlled for the differences between avoidable and unavoidable deaths without omitting the latter; from RePLY-DEA to RCPLY-DEA, we have controlled for the differences in resources across countries; and finally from RCPLY-DEA to RCPLY-SFA to control for stochastic variation in the measured mortality rate. An important merit of the RCPLY measures, either DEA or SFA based, is that they provide a method to integrate multiple key economic and health concepts together into a single framework; those concepts include resources (income), efficiency, health status, health inequality, avoidable and unavoidable deaths.
In a recent review of efficiency analyses of OECD health care sectors, Häkkinen and Joumard (2007) point out that, at the system (i.e. aggregate) level, avoidable deaths is a more relevant health status measure than life expectancy, but there is no agreed framework for applying this concept. Both the RePLY and RCPLY frameworks may provide a possible solution to this problem. On the other hand, although RCPLY has controlled for an additional factor, income, it does not immediately imply that it is definitely preferred to RePLY. Which indicator should be used depends on the task on hand. For instance, if the objective is to examine how within-country health inequality varies across countries, then controlling for country resources will make the comparison more meaningful and, thus, RCPLY should be used. On the other hand, if the objective is to estimate world-wide health inequality, then a global standard in measuring health status will be essential and hence RePLY should be used instead. In other words, RCPLY is more useful for estimating health inequality within countries, while RePLY is more useful for estimating health inequality across countries. In the case of output orientation, the technical efficiency score is the actual output as a proportion of the maximum possible output for the given input. In the case of input orientation, the technical efficiency score is the minimum possible input that could produce the given output as a proportion of the actual input. In the current content of output being health status and input being income per capita, it is appropriate to use output orientation.
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2. In the case of SFA, the significance of technical inefficiency can be tested using pp.259).
3. In both DEA and SFA estimations, the TE scores are measured for individual age/sex groups. But they can be aggregated up using population size as the weight to a national TE score.
4. One disadvantage with using the WHO dataset is that many probabilities of death for each age/sex/country groups have been estimated and smoothed out using all available data. While this may sound advantageous it does leave us with the problem of not knowing the associated variance around each estimate, which is important to control for the heteroskedasticity present in our logit model. 
